Literature DB >> 28512674

Preparing pathology for precision medicine: challenges and opportunities.

Karen L Kaul1,2.   

Abstract

Keywords:  DNA analysis; Genomic pathology; Next-generation sequencing; Personalized medicine; Somatic mutations

Mesh：

Year:  2017        PMID： 28512674     DOI： 10.1007/s00428-017-2141-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  24 in total

1.  Mass-spectrometry-based draft of the human proteome.

Authors:  Mathias Wilhelm; Judith Schlegl; Hannes Hahne; Amin Moghaddas Gholami; Marcus Lieberenz; Mikhail M Savitski; Emanuel Ziegler; Lars Butzmann; Siegfried Gessulat; Harald Marx; Toby Mathieson; Simone Lemeer; Karsten Schnatbaum; Ulf Reimer; Holger Wenschuh; Martin Mollenhauer; Julia Slotta-Huspenina; Joos-Hendrik Boese; Marcus Bantscheff; Anja Gerstmair; Franz Faerber; Bernhard Kuster
Journal:  Nature       Date:  2014-05-29       Impact factor: 49.962

2.  Next-Generation Sequencing in Cancer Diagnostics.

Authors:  Christopher L Corless
Journal:  J Mol Diagn       Date:  2016-09-21       Impact factor: 5.568

3.  Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma.

Authors:  Suzanne Kamel-Reid; Tong Zhang; Diane L Persons; Marina N Nikiforova; Kevin C Halling
Journal:  Arch Pathol Lab Med       Date:  2012-01       Impact factor: 5.534

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 6.  Implementing personalized cancer genomics in clinical trials.

Authors:  Richard Simon; Sameek Roychowdhury
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

7.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.

Authors:  Michael A Quail; Miriam Smith; Paul Coupland; Thomas D Otto; Simon R Harris; Thomas R Connor; Anna Bertoni; Harold P Swerdlow; Yong Gu
Journal:  BMC Genomics       Date:  2012-07-24       Impact factor: 3.969

8.  Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Authors: 
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

9.  Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.

Authors:  Torsten Nielsen; Brett Wallden; Carl Schaper; Sean Ferree; Shuzhen Liu; Dongxia Gao; Garrett Barry; Naeem Dowidar; Malini Maysuria; James Storhoff
Journal:  BMC Cancer       Date:  2014-03-13       Impact factor: 4.430

10.  Guidelines for diagnostic next-generation sequencing.

Authors:  Gert Matthijs; Erika Souche; Mariëlle Alders; Anniek Corveleyn; Sebastian Eck; Ilse Feenstra; Valérie Race; Erik Sistermans; Marc Sturm; Marjan Weiss; Helger Yntema; Egbert Bakker; Hans Scheffer; Peter Bauer
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246
View more
  3 in total

1.  Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.

Authors:  Yajian Wang; Haijing Liu; Yingyong Hou; Xiaoyan Zhou; Li Liang; Zhihong Zhang; Huaiyin Shi; Sanpeng Xu; Peizhen Hu; Zuyu Zheng; Rui Liu; Tingdong Tang; Feng Ye; Zhiyong Liang; Hong Bu
Journal:  Virchows Arch       Date:  2018-04-28       Impact factor: 4.064

2.  The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?

Authors:  Cristina Pelliccia; Emanuele Caselli; Martina Mandarano; Rachele Del Sordo; Guido Bellezza; Angelo Sidoni
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

3.  Application of a treatment planning system-assisted large-aperture computed tomography simulator to percutaneous biopsy: initial experience of a radiation therapist.

Authors:  Xiaoyi Lin; Liqin Ma; Kaixin Du; Junqiang Hong; Shuiying Luo; Youqun Lai; Yongliang Dai; Xiangquan Kong
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.